| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |